Skip to main content
. 2018 Mar 27;13(3):e0194205. doi: 10.1371/journal.pone.0194205

Table 1. Clinical and serologic variables of the studied subjects.

Healthy Relatives RA patients P value
Anti-CCP2+
N = 12
Anti-CCP2-
N = 12
N = 10
Age, yrs., mean ± SD 35 ± 8.7 43 ± 14.8 41 ± 9.8 0.257
Female (%) 75 91 80 0.534
Anti-CCP2 (U/ml), mean ± SD) 35 ± 5.4* 13 ± 1.7 194 ± 238.9* 0.0001
FR (IU/ml, mean ± SD) 6 ±3.5 7 ± 9.1 181 ± 178.2* <0.0001
DAS28 NA NA 5.8 ± 1.2 -

*Indicates significant differences for the anti-CCP2- group.